C
Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
ASX:CU6
Price:
3.33
AUD
-3.2%
Market Closed
Market Cap:
AU$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
|
Hologic Inc
NASDAQ:HOLX
|
US |
|
C
|
Coastal Contracts Bhd
KLSE:COASTAL
|
MY |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
P
|
Puregold Price Club Inc
XPHS:PGOLD
|
PH |
|
G
|
Greenland Holdings Corp Ltd
SSE:600606
|
CN |
|
I-PEX Inc
TSE:6640
|
JP |
|
Manitou BF SA
PAR:MTU
|
FR |
|
Northern Oil and Gas Inc
NYSE:NOG
|
US |
|
Toyo Wharf & Warehouse Co Ltd
TSE:9351
|
JP |
|
Helical PLC
LSE:HLCL
|
UK |
|
N
|
Nusasiri PCL
SET:NUSA
|
TH |
Income Statement
Earnings Waterfall
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Income Statement
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Currency: AUD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
12
N/A
|
12
+1%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(26)
|
(33)
|
(45)
|
(56)
|
(69)
|
(96)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(10)
|
(12)
|
(11)
|
(17)
|
|
| Research & Development |
(31)
|
(36)
|
(46)
|
(55)
|
(67)
|
(89)
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
10
|
9
|
12
|
11
|
9
|
11
|
|
| Operating Income |
(26)
N/A
|
(33)
-24%
|
(45)
-37%
|
(56)
-26%
|
(69)
-23%
|
(96)
-39%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
2
|
2
|
3
|
8
|
5
|
0
|
|
| Pre-Tax Income |
(24)
N/A
|
(30)
-24%
|
(42)
-38%
|
(48)
-15%
|
(64)
-32%
|
(96)
-50%
|
|
| Net Income | |||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Income from Continuing Operations |
(25)
|
(31)
|
(42)
|
(49)
|
(64)
|
(96)
|
|
| Net Income (Common) |
(25)
N/A
|
(31)
-24%
|
(42)
-38%
|
(49)
-15%
|
(64)
-32%
|
(96)
-50%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.12
-33%
|
-0.15
-25%
|
-0.16
-7%
|
-0.2
-25%
|
-0.28
-40%
|
|
Switch to:
Switch to:
See Also
Discover More
